AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+29.93%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.38B
AUM Growth
+$2.38B
(-39%)
Cap. Flow
-$2.22B
Cap. Flow
% of AUM
-93.38%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
109
New
–
Increased
–
Reduced
2
Closed
107
Top Buys
No buys this quarter
Top Sells
| 1 |
CAVA Group
CAVA
|
$743M |
| 2 |
Scholar Rock
SRRK
|
$93.8M |
| 3 |
Kymera Therapeutics
KYMR
|
$89.7M |
| 4 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$86.1M |
| 5 |
Arrowhead Research
ARWR
|
$82.9M |
Sector Composition
| 1 | Consumer Discretionary | 91.02% |
| 2 | Healthcare | 8.98% |
| 3 | Communication Services | 0% |
| 4 | Real Estate | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cartesian Therapeutics
RNAC
$267M
| – | – |
-304,554
| Closed | -$8.23M |
|
77
Revolution Medicines
RVMD
$7.43B
| – | – |
-1,015,776
| Closed | -$39.4M |
|
78
Sea Limited
SE
$107B
| – | – |
-97,500
| Closed | -$6.96M |
|
79
Seer Inc
SEER
$114M
| – | – |
-4,750,000
| Closed | -$7.98M |
|
80
Sagimet Biosciences
SGMT
$239M
| – | – |
-724,771
| Closed | -$2.48M |
|
81
Solid Biosciences
SLDB
$448M
| – | – |
-2,500,000
| Closed | -$14.2M |
|
|
SLN
82
Silence Therapeutics
SLN
$237M
| – | – |
-2,779,619
| Closed | -$52.8M |
|
|
SLRN
83
DELISTED
ACELYRIN
SLRN
| – | – |
-2,020,888
| Closed | -$8.91M |
|
84
Snowflake
SNOW
$76.5B
| – | – |
-5,051
| Closed | -$682K |
|
|
85
Scholar Rock
SRRK
$3.3B
| – | – |
-11,259,438
| Closed | -$93.8M |
|
|
SWTX
86
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-1,313,026
| Closed | -$49.5M |
|
87
Tango Therapeutics
TNGX
$745M
| – | – |
-2,519,841
| Closed | -$21.6M |
|
88
Tourmaline Bio
TRML
$645M
| – | – |
-91,426
| Closed | -$1.18M |
|
89
Taysha Gene Therapies
TSHA
$791M
| – | – |
-4,354,214
| Closed | -$9.75M |
|
90
Tesla
TSLA
$1.08T
| – | – |
-2,000
| Closed | -$396K |
|
91
TSMC
TSM
$1.2T
| – | – |
-26,000
| Closed | -$4.52M |
|
92
Visa
V
$681B
| – | – |
-19,000
| Closed | -$4.99M |
|
93
Vera Therapeutics
VERA
$1.47B
| – | – |
-915,974
| Closed | -$33.1M |
|
|
VIGL
94
DELISTED
Vigil Neuroscience
VIGL
| – | – |
-1,828,691
| Closed | -$7.31M |
|
95
Wave Life Sciences
WVE
$1.27B
| – | – |
-4,566,251
| Closed | -$22.8M |
|
96
Xenon Pharmaceuticals
XENE
$2.99B
| – | – |
-381,554
| Closed | -$14.9M |
|
97
Alto Neuroscience
ANRO
$97.7M
| – | – |
-350,000
| Closed | -$3.74M |
|
98
Kyverna Therapeutics
KYTX
$161M
| – | – |
-200,000
| Closed | -$1.5M |
|
99
Metagenomi
MGX
$67.2M
| – | – |
-300,000
| Closed | -$1.22M |
|
100
Rubrik
RBRK
$17B
| – | – |
-35,000
| Closed | -$1.07M |
|